electroCore,

electroCore, Total Assets

The Total Assets of electroCore, (ECOR) as of Oct 19, 2026 is 18.67 M USD. In the previous year, Total Assets was 20.47 M USD — a change of -8.81% (lower).

Total Assets

18.67 MUSD

YoY

-8.81%

Last updated:

Total Assets of electroCore, is 2025 18.67 M USD. Total Assets of electroCore, was 2024 20.47 M USD. It decreases by -8.81% lower compared to the previous year.

The electroCore, Total Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Total Assets
Date
Total Assets
Jan 1, 2018
73.50 M USD
Jan 1, 2019
35.46 M USD
Jan 1, 2020
31.52 M USD
Jan 1, 2021
42.83 M USD
Jan 1, 2022
24.76 M USD
Jan 1, 2023
16.10 M USD
Jan 1, 2024
20.47 M USD
Jan 1, 2025
18.67 M USD
The electroCore, Total Assets history
YEARTotal AssetsYoY
18.67 MUSD-8.81%
20.47 MUSD+27.13%
16.10 MUSD-34.96%
24.76 MUSD-42.20%
42.83 MUSD+35.90%
31.52 MUSD-11.12%
35.46 MUSD-51.76%
73.50 MUSD+87.35%
39.23 MUSD+6,207.34%
622,016.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

electroCore, Stock analysis

What does electroCore, do? electroCore, Inc. is a medical device company based in Basking Ridge, New Jersey, operating in the Health Care sector. The company focuses on non-invasive vagus nerve stimulation (nVNS) therapy, offering a hand-held device called gammaCore. This device provides non-drug treatment for adults experiencing episodic cluster and migraine pain. electroCore's technology targets primary headaches, including migraine and cluster headache, as well as related chronic conditions such as gastric motility disorders, psychiatric issues, sleep disorders, and pain disorders. The company went public via an IPO on June 22, 2018, and currently employs 83 full-time staff. Its headquarters are located in Basking Ridge, and it operates within the Health Care industry. electroCore's primary product, gammaCore, is designed for non-invasive cervical vagus nerve stimulation, aiming to address neurological, psychiatric, gastroenterological, and respiratory conditions. The company's website is https://www.electrocore.com/. electroCore is listed under the ticker ECOR with ISIN US28531P2020. The firm's commercial stage operations emphasize non-invasive therapeutic solutions without pharmaceutical intervention. electroCore, is one of the most popular companies on Eulerpool.

Frequently Asked Questions about electroCore, stock

Total Assets of electroCore, is 18.67 M USD in 2025.

Total Assets of electroCore, changed from 20.47 M USD to 18.67 M USD, representing a -8.81% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Assets electroCore, since 2006 – with annual values, charts, and detailed analysis.

Total assets represent everything a company owns, including cash, inventory, property, and intangible assets. It is a key measure of a company's size and resource base.

Total Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Assets's electroCore, historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — electroCore,

All Key Metrics — electroCore,